Results 1 to 10 of about 77,191 (247)

GMP-manufactured CRISPR/Cas9 technology as an advantageous tool to support cancer immunotherapy

Journal of Experimental & Clinical Cancer Research
Background CRISPR/Cas9 system to treat human-related diseases has achieved significant results and, even if its potential application in cancer research is improving, the application of this approach in clinical practice is still a nascent technology ...
M Caforio, S Iacovelli, C Quintarelli, F Locatelli, Valentina Folgiero   +4 more
doaj   +1 more source

Good Manufacturing Practices Evaluation in the Na Oogst Cigar Industry Center of Jember Regency: A Case Study of CV. Dwipa Nusantara Tobacco

Jurnal Manajemen Agribisnis dan Agroindustri
Good Manufacturing Practices (GMP) are essential for maintaining product safety, hygiene, and consistency in the cigar manufacturing industry. This study evaluates the level of GMP compliance at CV.
Nanang Dwi Wahyono, Kurniawan Muhammad Nur, Mohammad Mirza Pratama , Dyah Kusuma Wardani, Aditya Wahyu Winadi Atmajaya, Fredy Eka Ardhi Pratama   +5 more
doaj   +1 more source

A Simple Kit for the Good-Manufacturing-Practice Production of [⁶⁸Ga]Ga-EDTA. [PDF]

Molecules, 2023
Skulska M, Falborg L.
europepmc   +1 more source

KAJIAN PENERAPAN GOOD MANUFACTURING PRACTICE (GMP) DI INDUSTRI RAJUNGAN PT.KELOLA MINA LAUT MADURA

Agrointek, 2016
Good manufacturing practice is the first step implementation of food safety regulation. PT. Kelola Mina Laut is one of chilled sea crab producers in Madura. It has four branches in Madura,those are in Tanjung Bumi, Noreh, Sampang, and Lobuk.
Bhiaztika Ristyanadi, Darimiyya Hidayati
doaj  

A Challenge: Controlling the Quality of Cell and Gene Therapies

CHIMIA, 2022
Christoph Meyer, Alexander Sandoval, Allyson Decker, Sophia Nguyen, Susan Barr, Andreas Wirth   +5 more
doaj   +1 more source

Good manufacturing practice production of CD34⁺ progenitor-derived NK cells for adoptive immunotherapy in acute myeloid leukemia. [PDF]

Cancer Immunol Immunother, 2023
de Jonge PKJD, van Hauten PMM, Janssen LD, de Goede AL, Berrien-Elliott MM, van der Meer JMR, Mousset CM, Roeven MWH, Foster M, Blijlevens N, Hobo W, Fehniger TA, Jansen JH, Schaap NPM, Dolstra H.   +14 more
europepmc   +1 more source

Molecular and functional characterization of GMP-manufactured neural stem cells and their extracellular vesicles for innovative therapeutic applications

Stem Cell Research & Therapy
Human neural stem cells (hNSCs) are promising candidates for regenerative medicine due to their self-renewal capacity, differentiation potential, and ability to modulate inflammation.
Martina Guzzetti, Letizia Mezzasoma, Davide Chiasserini, Lara Macchioni, Magdalena Davidescu, Alessandro di Michele, Marco Gargaro, Nicola Di-Iacovo, Giorgia Manni, Gianmarco Muzi, Ilaria Proietti, Giuseppina Bevacqua, Eleonora Becattini, Carlo Conti, Vincenzo Nicola Talesa, Rita Romani, Ilaria Bellezza, Valentina Grespi   +17 more
doaj   +1 more source

Evaluation of the Implementation of Good Manufacturing Practice at the Slaughterhouse in Kolaka Regency

Jurnal Agripet
Meat safety is a major component of food safety that impacts public health, so supervision and protection are needed. This study aims to analyze the level of Good Manufacturing Practices (GMP) implementation in providing safe, healthy, intact, and halal (
Nur Santy Asminaya, Fuji Astuti Auza, Ali Bain, La Ode Nafiu, La Malesi, Deki Zulkarnain, Titin Tambing   +6 more
doaj   +1 more source

REVIEW, CHARACTERISTICS AND ANALYSIS OF THE LAST CHANGES IN THE GMP REQUIREMENTS

Разработка и регистрация лекарственных средств, 2019
The regulatory requirements are constantly increasing in the medicines manufacturing sphere, which is reflected in the good manufacturing practice rules.
Yu. V. Podpruznikov, V. N. Shestakov
doaj  

Closed-system manufacturing of therapeutic NK cells using automated cell enrichment and concentration processes enables scalable, robust and cost-effective solutions

Frontiers in Bioengineering and Biotechnology
BackgroundCell therapy is a promising field with the potential to improve outcomes for cancer and autoimmune disease patients. However, its complex and resource-intensive manufacturing requires costly infrastructure.
Nina Kok, Zoë Dekkers, Anica Loos, Thomas Bos, Puck van den Broek, Inge Post, Bertine Niessen, Jan Spanholtz, Volker Huppert, Monica Raimo   +9 more
doaj   +1 more source